Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine (Q46686021)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine |
scientific article |
Statements
1 reference
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine (English)
1 reference
Kurt Rasmussen
1 reference
Mark J Benvenga
1 reference
Frank P Bymaster
1 reference
David O Calligaro
1 reference
Ilene R Cohen
1 reference
Julie F Falcone
1 reference
Susan K Hemrick-Luecke
1 reference
Fionna M Martin
1 reference
Nicholas A Moore
1 reference
Laura K Nisenbaum
1 reference
John M Schaus
1 reference
Sarah J Sundquist
1 reference
David E Tupper
1 reference
Todd R Wiernicki
1 reference
David L Nelson
1 reference
1 September 2005
1 reference
315
1 reference
3
1 reference
1265-1277
1 reference
Identifiers
1 reference